ProCE Banner Activity

Clinical Data on TROP2-Targeting ADCs in Breast, Urothelial, and Lung Cancers

Slideset

Download this slideset from a live CCO symposium for nurses to get up to date on the latest clinical data for the TROP2 ADCs sacituzumab govitecan and datopotamab deruxtecan across multiple tumor types. 

Released: April 28, 2023

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.